---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-013625"
form_type: "8-K"
ticker: "VCEL"
cik: "0000887359"
company_name: "Vericel Corp"
filed_at: "2025-04-14T23:59:59+00:00"
generated_at: "2026-05-23T15:53:02.529234+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Vericel sees negligible impact from U.S. tariffs on COGS and gross margin

## Summary
- All operations in U.S.; 100% of 2025 revenue from domestic sales.
- Majority of manufacturing costs are fixed labor/overhead for MACI and Epicel.
- Materials primarily from U.S. suppliers; imported material costs limited.
- Maintains safety stock of NexoBrid and ACI-Maix collagen membrane.
- Expects negligible impact on COGS and gross margin in 2025 and 2026.

## SEC filing metadata
- accession: 0001140361-25-013625
- form_type: 8-K
- ticker: VCEL
- cik: 0000887359
- company_name: Vericel Corp
- filed_at: 2025-04-14T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/887359/000114036125013625/0001140361-25-013625-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/887359/000114036125013625/ef20047328_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-013625
- JSON: https://secwatch.observer/filing/0001140361-25-013625.json
- Plain text: https://secwatch.observer/filing/0001140361-25-013625.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.